Menu
Search Close

News

Webcasts, Interviews and Media Coverage

Scancell Holdings makes two experience hires as it gears up for the next development phase

The company has brought in outside research and manufacturing expertise

Mon, 21 Jan 2019 07:29:00

Scancell’s Modi-2 anti-cancer vaccine shows potential in pre-clinical studies

Modi-2 is the second vaccine developed from the Moditope platform after Modi-1, and Scancell thinks each one has the potential to treat different types of cancer

Tue, 30 Oct 2018 14:05:00

Scancell says it is working closely with US regulators ahead of phase II study of cancer immunotherapy

The UK group is planning to use its SCIB1 in harness with Merck’s Keytruda to treat patients with advanced melanoma

Wed, 24 Oct 2018 05:40:00